Genomictree Market Cap

Genomictree has a market cap or net worth of 420.17 billion as of April 30, 2026. Its market cap has increased by 13.36% in one year.

Market Cap

420.17B

Enterprise Value

345.41B

Revenue

3.76B

Ranking

n/a

PE Ratio

n/a

Stock Price

17,150.00

Market Cap Chart

Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 420.17B, an increase of 612.16%. That is a compound annual growth rate of 24.15%.

Market Cap History

Date	Market Cap	% Change
Apr 30, 2026	420.17B	-36.28%
Dec 30, 2025	659.41B	34.41%
Dec 30, 2024	490.60B	0.78%
Dec 28, 2023	486.82B	168.25%
Dec 29, 2022	181.48B	-32.87%
Dec 30, 2021	270.36B	-7.66%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Apr 5, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Proteina	669.50B
GC Corp.	633.81B
SillaJen	482.76B
Helixmith	396.92B
BINEX	363.70B
Anterogen.Co.,Ltd.	360.22B
GC Cell	356.89B
HLB Therapeutics	326.75B

Market Cap Rankings